Triglycerides are the main form of fat in your blood and a key component of a standard lipid panel. Fasting levels above 150 mg/dL are considered elevated and associated with increased cardiovascular risk, especially when combined with low HDL or high LDL. Lifestyle factors—diet (especially refined carbs and alcohol), physical inactivity, and excess weight—are the primary drivers. Genetic variants in LPL, APOA5, and APOC3 can also raise triglycerides, but their effect is modest. MyBody-X offers triglyceride measurement as part of its lipid panel; however, a single elevated reading should be confirmed and interpreted alongside other markers like ApoB, non-HDL cholesterol, and Lp(a) for a complete risk picture. Evidence for triglycerides as a cardiovascular risk marker is strong (human-strong), but drug trials targeting isolated triglyceride reduction have shown mixed results. Lifestyle intervention (Mediterranean diet, omega-3s, exercise, weight loss) remains the most effective strategy. Caveat: Non-fasting samples can be misleading; always measure after 8–12 hours of fasting. Very high levels (>500 mg/dL) increase pancreatitis risk and require medical attention. Consumer DNA tests may include triglyceride-related SNPs, but they cannot replace blood testing and have limited predictive power.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4783cc89b18cef07a159653d